Hims & Hers struck a GLP-1 deal with Lilly. Its stock is rallying.

Hims & Hers struck a GLP-1 deal with Lilly. Its stock is rallying.

来源:Market Watch发布于 2026-11-06

As part of the agreement, Hims said it won't compound GLP-1 medications like Zepbound in the future.

相关标的:HIMSLLY

本文内容来自外部来源,点击「继续访问」将跳转到原始发布站点。